PharmaCyte Biotech (PMCB) EBITDA (2009 - 2013)
PharmaCyte Biotech (PMCB) reported EBITDA of -$455,186 for fiscal Q4 2013 (quarter ended Apr 30, 2013), compared with -$482,064 a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) EBITDA (2009 - 2013) Analysis & Trends
For FY2013 (ended Apr 30, 2013), PharmaCyte Biotech posted EBITDA of -$1.68 million.
- By fiscal year, EBITDA came in at -$1.92 million in FY2012 and -$347,673 in FY2011.
- Five-year quarterly EBITDA spans a low of -$644,077 in fiscal Q1 2012 and a high of -$8,214 in fiscal Q2 2011.
- Per Business Quant data, the three fiscal quarters before Q4 2013 came in at -$340,840 (Q3 2013), -$348,796 (Q2 2013) and -$538,786 (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2013 | -455,186.00 |
| Jan 31, 2013 | -340,840.00 |
| Oct 31, 2012 | -348,796.00 |
| Jul 31, 2012 | -544,481.00 |
| Apr 30, 2012 | -484,765.00 |
| Jan 31, 2012 | -405,209.00 |
| Oct 31, 2011 | -398,573.00 |
| Jul 31, 2011 | -646,776.00 |
| Apr 30, 2011 | -215,307.00 |
| Jan 31, 2011 | -62,241.00 |
| Oct 31, 2010 | -10,913.00 |
| Jul 31, 2010 | -70,011.00 |
| Apr 30, 2010 | -2.53 Mn |
| Jan 31, 2010 | -34,157.00 |
| Oct 31, 2009 | -454,628.00 |
| Jul 31, 2009 | -935,747.00 |
| Apr 30, 2009 | -4.17 Mn |
| Jan 31, 2009 | -883,571.00 |
API Access
PharmaCyte Biotech EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();